Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 1/20 | 0.36 |
| ▸ | TACR3 | P29371 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.30 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2867820 | 0.89 | TAS1R3 (0.31) | KDM4EALDH1A1HPGDTAS1R3TAS1R1 | |
| SCHEMBL2524404 | 0.84 | ALOX5 (0.39) | KDM4EALDH1A1HPGD | |
| SCHEMBL1095842 | 0.84 | ALOX5 (0.39) | KDM4EALDH1A1HPGD | |
| SCHEMBL5185602 | 0.80 | CASP3 (0.35) | CHEK1KDM4EALDH1A1HPGDALOX12 | |
| SCHEMBL1897757 | 0.78 | ALDH1A1 (0.40) | TACR3ALDH1A1TAS1R3TAS1R1 | |
| SCHEMBL31373087 | 0.78 | ALDH1A1 (0.40) | TACR3ALDH1A1TAS1R3TAS1R1 | |
| SCHEMBL2683123 | 0.78 | CHEK1 (0.31) | CHEK1 | |
| SCHEMBL6794605 | 0.77 | MEN1 (0.37) | KDM4EALDH1A1HPGDALOX12 | |
| SCHEMBL8975870 | 0.76 | TAS1R3 (0.38) | TACR3TAS1R3TAS1R1 | |
| SCHEMBL9511404 | 0.76 | KDM4E (0.38) | KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090197802-A1 | Analogues of GLP-1 | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (FR) | 2009-08-06 | — | — | US | claimed |
| WO-2009027952-A1 | BENZOTERRYLENE DERIVATIVES | SABIC INNOVATIVE PLASTICS IP B.V. (US) | 2009-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090197802-A1 | Analogues of GLP-1 | GLP1R, IAPP, GIPR | CHEK1 4859/4885TACR3 403/4885KDM4E 3870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.